Exercise

Novo Exercises Option Over GBM Resources’ Malmsbury Gold Project

Thursday, September 24, 2020 - 2:01pm

VANCOUVER, British Columbia, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has exercised its option to earn a 50% interest (the Interest) in the Malmsbury gold project (the Malmsbury Project) held by ASX-listed GBM Resources Limited (ASX: GBZ) (GBM).

Key Points: 
  • VANCOUVER, British Columbia, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has exercised its option to earn a 50% interest (the Interest) in the Malmsbury gold project (the Malmsbury Project) held by ASX-listed GBM Resources Limited (ASX: GBZ) (GBM).
  • We are pleased to exercise our option over the Malmsbury project, commented Quinton Hennigh, Chairman and President of Novo.
  • Novo believes that it now holds one of the most prospective high-grade gold projects in the Victorian gold fields.
  • Upon satisfaction of the Conditions, Novo will issue 1,575,387 common shares (the Option Shares) to GBM as consideration for the exercise of the option.

Ampco-Pittsburgh Corporation (NYSE: AP) Announces 93% Subscription for its Rights Offering and Extension of Expiration Date to Friday, September 18, 2020

Thursday, September 17, 2020 - 12:46pm

All basic subscription rights and over-subscription privileges may be exercised during the subscription period of Tuesday, August 18, 2020, through the Extended Expiration Time at 5:00 PM Eastern Time, Friday, September 18, 2020.

Key Points: 
  • All basic subscription rights and over-subscription privileges may be exercised during the subscription period of Tuesday, August 18, 2020, through the Extended Expiration Time at 5:00 PM Eastern Time, Friday, September 18, 2020.
  • If a rights holder does not exercise their subscription rights before the Extended Expiration Time, such rights will be deemed expired and void and will have no value.
  • Such rights holders will then own the same number of the Corporations common shares as before the commencement of the rights offering.
  • A copy of the prospectus and related materials were sent to holders of record on August 17, 2020.

The Evolution of Exercise

Thursday, September 17, 2020 - 12:01am

At the beginning of lockdown, many saw this time as opportunity for self-improvement and used the additional time as a chance to exercise.

Key Points: 
  • At the beginning of lockdown, many saw this time as opportunity for self-improvement and used the additional time as a chance to exercise.
  • Fuel your exercise the right way:Carbohydrate is the body's primary source of fuel and is a particularly important macronutrient to maximise workouts.
  • 65% of our body consists of water and dehydration can have a huge impact on exercise performance energy and even mood.
  • Building recovery time into any training programme is important as it allows the body to replenish energy stores, repair damaged tissue and adapt to exercise stress.

GOGL – Grant of stock options

Monday, September 14, 2020 - 4:00pm

Golden Ocean Group Limited (Golden Ocean or the Company) hereby announces that 275,000 share options have today been granted to Mr Peder Simonsen in connection with his appointment as CFO of Golden Ocean Management AS.

Key Points: 
  • Golden Ocean Group Limited (Golden Ocean or the Company) hereby announces that 275,000 share options have today been granted to Mr Peder Simonsen in connection with his appointment as CFO of Golden Ocean Management AS.
  • The share options will have a five-year term expiring September 4, 2025, and will vest equally one third over a three-year vesting period.
  • 75,000 of the share options will vest on September 4, 2021, with an exercise price of NOK 32.- each
    75,000 of the share options will vest on September 4, 2022, with an exercise price of NOK 48.- each
    125,000 of the share options will vest on September 4, 2023, with an exercise price of NOK 64.- each
    The exercise price will be adjusted for any distribution of dividends made before the relevant options are exercised.

Avricore Health Amends Options

Friday, September 11, 2020 - 4:43am

VANCOUVER, British Columbia, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Avricore Health Inc.(TSXV: AVCR) (the "Company" or Avricore) announces that its Board of Directors and Shareholders have approved (subject to TSXV approval) the re-pricing of a total of 2,091,072 options to purchase common shares ("Options") to an amended exercise price of $0.10 per Option (the "Re-Pricing").

Key Points: 
  • VANCOUVER, British Columbia, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Avricore Health Inc.(TSXV: AVCR) (the "Company" or Avricore) announces that its Board of Directors and Shareholders have approved (subject to TSXV approval) the re-pricing of a total of 2,091,072 options to purchase common shares ("Options") to an amended exercise price of $0.10 per Option (the "Re-Pricing").
  • 150,000 of the Options had been issued on July 20, 2017 with an original exercise price of $0.15.
  • 150,000 of the Options had been issued on September 27, 2017 at an original exercise price of $0.15.
  • 150,000 of the Options had been issued on April 11, 2018 at an original exercise price of $0.21 and 140,000 of the Options had been issued on September 12, 2018 at an original exercise price of $0.125.

Feinstein Institutes Receives $1.7M Grant to Study Behavior Change Science, Promote Exercise in Older Adults  

Wednesday, September 9, 2020 - 2:41pm

To better understand the benefits and develop behavior change interventions to promote physical activity in older adults, researchers at the Feinstein Institutes for Medical Research have been awarded a $1.7 million grant from the National Institute on Aging (NIA).

Key Points: 
  • To better understand the benefits and develop behavior change interventions to promote physical activity in older adults, researchers at the Feinstein Institutes for Medical Research have been awarded a $1.7 million grant from the National Institute on Aging (NIA).
  • They will then assess and develop pilot study programs with participants in an effort to determine the best methods to help increase exercise and decrease sedentary behavior.
  • We hope to identify intervention strategies to change the behavior of adults and promote exercises that can improve the quality of their lives.
  • Dr. Davidson is a leader in behavior research and in identifying factors underlying behavioral change, said Kevin J. Tracey, MD , president and CEO of the Feinstein Institutes.

DGAP-News: Delivery Hero SE: Issuance of new shares in connection with existing stock option program and completed sale of shares for beneficiaries

Monday, September 7, 2020 - 8:02pm

0.05% of Delivery Hero's registered share capital, will be issued to beneficiaries of the stock option program who have exercised their stock options.

Key Points: 
  • 0.05% of Delivery Hero's registered share capital, will be issued to beneficiaries of the stock option program who have exercised their stock options.
  • 67,929 existing shares have been sold over the market upon instruction and for the account of certain beneficiaries, inter alia, so that they can finance the exercise prices and income taxes.
  • The securities of Delivery Hero SE have not been, and will not be, registered under the Securities Act.
  • In connection with the transaction described above (the 'Placement'), UniCredit Bank AG is acting exclusively for Delivery Hero SE.

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Friday, September 4, 2020 - 9:05pm

The equity awards were approved on April 30, 2020, July 14, 2020, July 30, 2020, and August 4, 2020, in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The equity awards were approved on April 30, 2020, July 14, 2020, July 30, 2020, and August 4, 2020, in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The employees received options to purchase 151,342 shares of Apellis common stock.
  • The options have an exercise price of $30.45, which is equal to the closing price of Apellis common stock on September 1, 2020, the grant date of the options.
  • Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies.

AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Friday, September 4, 2020 - 12:00pm

The stock options was granted on Sept. 1, 2020, with an exercise price of $16.40 per share, representing the closing price of AVROBIOs common stock as reported by Nasdaq on the grant date.

Key Points: 
  • The stock options was granted on Sept. 1, 2020, with an exercise price of $16.40 per share, representing the closing price of AVROBIOs common stock as reported by Nasdaq on the grant date.
  • Vesting of the option award is subject to continued service with AVROBIO by the employee through the applicable vesting dates.
  • AVROBIO is powered by the plato gene therapy platform, our foundation designed to scale gene therapy worldwide.
  • AVROBIO explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

EGYM Virtual Expert Series - New Episode: The Science of Aging and Why it Matters

Wednesday, September 2, 2020 - 11:00am

The number of Americans ages 65 and older in the U.S. will more than double in the next forty years.

Key Points: 
  • The number of Americans ages 65 and older in the U.S. will more than double in the next forty years.
  • The science of aging, therefore, is an important topic to explore as we are starting to understand more and more about the benefits of exercise as people age.
  • What Exactly Is The Science Of Aging?
  • Being that Mike Studer is one of the leading thinkers on the science of aging, his insights will be a tremendous value to many."